Product Code: ETC067008 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Philippines non-oncology precision medicine market is expected to grow significantly over the forecast period due to increasing demand for personalized healthcare. With rising prevalence of chronic diseases, such as diabetes, cardiovascular and neurological disorders, the need for more efficient and cost effective therapies has grown exponentially. This segment includes drug development targeted at specific patient populations based on individual???s genetic makeup or physiological condition. As a result, it offers better disease management with improved effectiveness and safety outcomes compared to traditional clinical practices
The growing adoption of informatics technologies in medical research can lead to new opportunities for precision medicine in the Philippines. Such technologies provide access to genomics data which enable doctors and researchers to analyze a person`s entire gene sequence quickly. Additionally, big data analytics are being used by hospital systems across the country in order to improve patient care delivery through personalized treatments plans tailored according to an individual???s needs and profile. Moreover, technological advancements have enabled providers like hospitals and clinics adopt advanced platforms that allow them store large volumes of genomic information along with its interpretation which further assists physicians make informed decisions while prescribing medicines or therapies
Growing awareness among patients about precision medicine coupled with increasing governmental initiatives supporting this field is anticipated drive growth of this market during 2025???2031 period. For instance, Philippine Department of Science & Technology (DOST) has funded numerous projects related towards advancing development of personalize diagnostics tools such as GeneEx tests which can detect mutation associated cancers accurately than other available standard methods so far developed globally.. Additionally supportive government policies encouraging foreign direct investments (FDI) from international players into local pharmaceutical industry will help propel market expansion during forecast timeframe . Furthermore , rise usage telemedicine services promoting remote healthcare consulting sessions without any physical presence will fuel sectoral growth going forward
Despite various drivers aiding current scenario , there certain challenges may hinder progress rate witnessed in short term especially due high costs involved setting up infrastructure required operate efficiently within precision space . Further lack skilled professionals particularly those work domain genomics cause operational hindrances potential investors looking enter arena . Lastly , slow approval process drugs relatively long time frame compared conventional medications present another major constraint faced relevant stakeholders currently active space
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Non-Oncology Precision Medicine Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Non-Oncology Precision Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Non-Oncology Precision Medicine Market - Industry Life Cycle |
3.4 Philippines Non-Oncology Precision Medicine Market - Porter's Five Forces |
3.5 Philippines Non-Oncology Precision Medicine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Philippines Non-Oncology Precision Medicine Market Revenues & Volume Share, By Ecosystem, 2021 & 2031F |
4 Philippines Non-Oncology Precision Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Non-Oncology Precision Medicine Market Trends |
6 Philippines Non-Oncology Precision Medicine Market, By Types |
6.1 Philippines Non-Oncology Precision Medicine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Philippines Non-Oncology Precision Medicine Market Revenues & Volume, By Application, 2018 - 2031F |
6.1.3 Philippines Non-Oncology Precision Medicine Market Revenues & Volume, By Neurology, 2018 - 2031F |
6.1.4 Philippines Non-Oncology Precision Medicine Market Revenues & Volume, By Endocrinology, 2018 - 2031F |
6.1.5 Philippines Non-Oncology Precision Medicine Market Revenues & Volume, By Life Sciences, 2018 - 2031F |
6.1.6 Philippines Non-Oncology Precision Medicine Market Revenues & Volume, By Cardiovascular, 2018 - 2031F |
6.1.7 Philippines Non-Oncology Precision Medicine Market Revenues & Volume, By Others, 2018 - 2031F |
6.2 Philippines Non-Oncology Precision Medicine Market, By Ecosystem |
6.2.1 Overview and Analysis |
6.2.2 Philippines Non-Oncology Precision Medicine Market Revenues & Volume, By Precision Diagnostics, 2018 - 2031F |
6.2.3 Philippines Non-Oncology Precision Medicine Market Revenues & Volume, By Digital Health and Information Technology, 2018 - 2031F |
6.2.4 Philippines Non-Oncology Precision Medicine Market Revenues & Volume, By Applied Sciences, 2018 - 2031F |
7 Philippines Non-Oncology Precision Medicine Market Import-Export Trade Statistics |
7.1 Philippines Non-Oncology Precision Medicine Market Export to Major Countries |
7.2 Philippines Non-Oncology Precision Medicine Market Imports from Major Countries |
8 Philippines Non-Oncology Precision Medicine Market Key Performance Indicators |
9 Philippines Non-Oncology Precision Medicine Market - Opportunity Assessment |
9.1 Philippines Non-Oncology Precision Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Philippines Non-Oncology Precision Medicine Market Opportunity Assessment, By Ecosystem, 2021 & 2031F |
10 Philippines Non-Oncology Precision Medicine Market - Competitive Landscape |
10.1 Philippines Non-Oncology Precision Medicine Market Revenue Share, By Companies, 2024 |
10.2 Philippines Non-Oncology Precision Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |